Ligand validation:4PLT

NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE

NAI is a Ligand Of Interest in 4PLT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4PLT_NAI_C_401	97%	43%	0.065	0.977	1.02	1.19	2	5	2	0	100%	1
4PLT_NAI_B_401	97%	44%	0.071	0.983	1.01	1.17	2	4	2	0	100%	1
4PLT_NAI_A_401	96%	39%	0.067	0.976	1.11	1.26	3	6	3	0	100%	1
4PLT_NAI_D_401	95%	41%	0.069	0.972	1.05	1.25	2	6	2	0	100%	1
4PLY_NAI_E_401	94%	45%	0.08	0.98	0.99	1.15	2	3	3	0	100%	1
4PLV_NAI_B_401	88%	46%	0.091	0.966	0.98	1.09	3	2	4	0	100%	1
9CP7_NAI_A_501	100%	55%	0.041	0.986	0.66	1.06	-	2	2	0	100%	1
4PLZ_NAI_A_402	100%	46%	0.048	0.993	0.9	1.18	-	4	3	0	100%	1
5W8K_NAI_B_402	100%	32%	0.044	0.988	1.22	1.47	5	8	0	0	100%	1
9CP8_NAI_A_501	100%	51%	0.043	0.985	0.88	1.02	1	2	2	0	100%	1
4PLF_NAI_A_401	100%	21%	0.049	0.991	1.29	2.02	6	9	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.